Deepak L Bhatt - JoVE Visualize

Showing results (1401-1410 of 1,708) with videos related to

Pageof 171

Sort By:

Journal of the American College of Cardiology|March 19, 2016

Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS TrialRenato D Lopes, Sergio Leonardi, Benjamin Neely, et al.

BMJ (Clinical Research Ed.)|August 2, 2015

Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) studyYing Xian, Jingjing Wu, Emily C O'Brien, et al.

Circulation|September 6, 2014

Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trialBenjamin M Scirica, Eugene Braunwald, Itamar Raz, et al.

Circulation|September 1, 2016

Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54)Marc P Bonaca, Shinya Goto, Deepak L Bhatt, et al.

European Heart Journal|April 2, 2026

Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesityMohamad B Kassab, Haitham Khraishah, Andrew Thrapp, et al.

American Journal of Preventive Cardiology|June 15, 2026

Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatmentGregory G Schwartz, Michael Szarek, Christa M Cobbaert, et al.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 10, 2020

Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stentsRidhima Goel, Davide Cao, Rishi Chandiramani, et al.

Stroke|September 15, 2016

Hospital Variation in Home-Time After Acute Ischemic Stroke: Insights From the PROSPER Study (Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research)Emily C O'Brien, Ying Xian, Haolin Xu, et al.

Journal of the American College of Cardiology|October 8, 2021

Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-ITPrakriti Gaba, Deepak L Bhatt, Robert P Giugliano, et al.

Circulation|October 28, 2021

Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENALArjun Majithia, Deepak L Bhatt, Allon N Friedman, et al.

Pageof 171

Showing results (1401-1410 of 1,708) with videos related to

Sort By:

Pageof 171

Journal of the American College of Cardiology|March 19, 2016

Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS TrialRenato D Lopes, Sergio Leonardi, Benjamin Neely, et al.

BMJ (Clinical Research Ed.)|August 2, 2015

Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) studyYing Xian, Jingjing Wu, Emily C O'Brien, et al.

Circulation|September 6, 2014

Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trialBenjamin M Scirica, Eugene Braunwald, Itamar Raz, et al.

Circulation|September 1, 2016

Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54)Marc P Bonaca, Shinya Goto, Deepak L Bhatt, et al.

European Heart Journal|April 2, 2026

Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesityMohamad B Kassab, Haitham Khraishah, Andrew Thrapp, et al.

American Journal of Preventive Cardiology|June 15, 2026

Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatmentGregory G Schwartz, Michael Szarek, Christa M Cobbaert, et al.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 10, 2020

Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stentsRidhima Goel, Davide Cao, Rishi Chandiramani, et al.

Stroke|September 15, 2016

Hospital Variation in Home-Time After Acute Ischemic Stroke: Insights From the PROSPER Study (Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research)Emily C O'Brien, Ying Xian, Haolin Xu, et al.

Journal of the American College of Cardiology|October 8, 2021

Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-ITPrakriti Gaba, Deepak L Bhatt, Robert P Giugliano, et al.

Circulation|October 28, 2021

Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENALArjun Majithia, Deepak L Bhatt, Allon N Friedman, et al.

Pageof 171